Viewing Study NCT01136161


Ignite Creation Date: 2025-12-24 @ 12:06 PM
Ignite Modification Date: 2025-12-27 @ 10:46 PM
Study NCT ID: NCT01136161
Status: COMPLETED
Last Update Posted: 2013-01-24
First Post: 2010-05-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTIĀ® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
Sponsor: Archivel Farma S.L.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module